Read in Spanish
Researchers from the Polytechnic University of Valencia developed together with the Hemp Trading company a cannabis genetics with high promise to treat cancer, Parkinson’s, Alzheimer’s and the psychoactive component Tetrahydrocannabinol (THC).
It is a variety that has change the accumulation of cannabigerol (CBG) inhibiting the later production of THC.
Follow us on instagram: @mcnglobal
Currently, in Spain, medical research to commercialize only allows working with non-psychoactive components.
This is explained by the CEO of Hemp Trading, Ernesto Llosá:
“The CBG is the first cannabinoid that forms in the cannabis plant, so it is considered a mother cel,” says Llosá.
Researchers have realized that CBG has a high potential for the nature of the precursor of the known THC and cannabidiol (CBD). As the plant grows stronger, the CBG almost disappears to give way to said cannabinoids.
“The plants with CBD contain a fraction of THC that has to be separated and discarded in the purification process In our case, the sale of CBG is pure, without the presence of other cannabinoids, that is, we make sure that it is free of THC Therefore, “We guarantee an absence of a psychoactive component,” said ABC.
This is one of 5 in the state. When finding this method to mitigate or eliminate the production of THC, other pharmaceutical companies could be interested in its development to have fewer obstacles at the legal level.
According to the article, ‘Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid retinal effect’ published in the British Journal of Pharmacology, it was discovered that CBG has characteristics similar to CBD.
Among them, the decrease of pain, the inhibition of cancer cells, the reduction of inflammation, the inducer of sleep and contains antidepressant properties. It could also be a powerful ally against glaucoma.
The European Union (EU) urged the state members to use medical research to create ways to access and systematize the information available.
Photo: Kimzy Nanney
Follow us on instagram: @mcnglobal
in Costa Rica. 
